Sildenafil + Placebo + Vardenafil (Levitra, BAY38-9456) + Placebo

ApprovedCompleted
0 watching 0 views this week๐Ÿ”ฅ Hot
82
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
โœ“
Phase 3
5
Approved
Indication / Disease

Safety

Conditions

Safety

Trial Timeline

Feb 1, 2005 โ†’ Oct 1, 2006

About Sildenafil + Placebo + Vardenafil (Levitra, BAY38-9456) + Placebo

Sildenafil + Placebo + Vardenafil (Levitra, BAY38-9456) + Placebo is a approved stage product being developed by Bayer for Safety. The current trial status is completed. This product is registered under clinical trial identifier NCT00461565. Target conditions include Safety.

Hype Score Breakdown

Clinical
30
Activity
20
Company
7
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT00461565ApprovedCompleted